Cancer

Partner Content

Partner Content

When science and biology combine – the outlook for ADCs in c...

Antibody Drug Conjugates (ADCs) are treatments formed by the conjugation of monoclonal antibodies and cytotoxic agents.

News

3D Japan flag (with clipping path)see more country...

Eisai: UK gives pharma a poor deal, may invest elsewhere

Japanese pharma getting frustrated with NICE

News

Merck KGaA/Pfizer's Bavencio fails in stomach cancer trial

Merck KGaA and Pfizer’s cancer immunotherapy Bavencio has disappointed in a hard to treat late-stage gastric cancer trial, failing to extend survival compared to chemotherapy.

News

Researchers start trial on AZ WEE1 drug in head and neck can...

Phase 1 trial investigates use before and after surgery

Partner Content

Partner Content

The first patient to be injected with an RNA based anti-canc...

RNA Therapeutics

News

NHS braces for tough winter, saying budget falls short

Cancer and A&E waiting times may not recover

When science and biology combine – the outlook for ADCs in c...

Eisai: UK gives pharma a poor deal, may invest elsewhere

Merck KGaA/Pfizer's Bavencio fails in stomach cancer trial

Researchers start trial on AZ WEE1 drug in head and neck can...

The first patient to be injected with an RNA based anti-canc...

NHS braces for tough winter, saying budget falls short

Making direct-to-patient work, with Matt Wadyka

Using AI-driven synthetic personas to take your insights fur...

Cancer

Editor's Picks